Bind Research
Bind Research is a UK-based not-for-profit Focused Research Organisation (FRO) dedicated to improving patient outcomes by transforming disordered proteins into viable drug targets. The organization aims to make disordered proteins druggable, which are often considered 'undruggable' by the pharmaceutical industry. By screening millions of disordered protein/drug-molecule pairs and leveraging cutting-edge biology, engineering, and AI, Bind Research is building comprehensive datasets to accelerate drug discovery. Their commitment to public benefit and collaboration with academic and industrial partners positions them uniquely in the market, promising new therapeutic avenues for diseases like cancer and neurodegeneration.
Bind Research
Bind Research is a UK-based not-for-profit Focused Research Organisation (FRO) dedicated to improving patient outcomes by transforming disordered proteins into viable drug targets. The organization aims to make disordered proteins druggable, which are often considered 'undruggable' by the pharmaceutical industry. By screening millions of disordered protein/drug-molecule pairs and leveraging cutting-edge biology, engineering, and AI, Bind Research is building comprehensive datasets to accelerate drug discovery. Their commitment to public benefit and collaboration with academic and industrial partners positions them uniquely in the market, promising new therapeutic avenues for diseases like cancer and neurodegeneration.